Universe Pharmaceuticals ...

0.12
-0.01 (-6.03%)
At close: Mar 03, 2025, 3:59 PM
0.12
3.10%
After-hours: Mar 03, 2025, 05:21 PM EST

Universe Pharmaceuticals INC Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 32.31M 40.14M 47.98M 30.7M 33.23M 28.51M
Cost of Revenue 21.99M 18.25M 22.66M 16.61M 19.82M 15.11M
Gross Profit 10.32M 21.89M 25.33M 14.09M 13.41M 13.41M
Operating Income -3.53M -7.02M 13.59M 10.25M 9.75M 9.66M
Interest Income n/a n/a 239.55K n/a n/a n/a
Pretax Income -3.85M -7.98M 13.68M 10.1M 9.65M 9.52M
Net Income -6.16M -8.74M 11.32M 7.56M 7.55M 7.6M
Selling & General & Admin 9M 20.84M 6.27M 2.8M 2.29M 2.39M
Research & Development 4.86M 7.64M 5.47M 583.13K 618.44K 789.38K
Other Expenses -17.53K 430.31K -80.43K 365.77K 445.77K 5.01K
Operating Expenses 13.84M 28.91M 11.74M 3.74M 3.36M 3.65M
Interest Expense 156.79K 162.4K 101.6K 123.76K 129.27K 164.92K
Selling & Marketing Expenses 6.78M 19.08M 2.97M 1.56M 1.58M 1.68M
Cost & Expenses 35.84M 47.16M 34.39M 20.35M 23.18M 18.75M
Income Tax 2.31M 752.42K 2.36M 2.54M 2.1M 1.92M
Shares Outstanding (Basic) 3.63M 3.63M 3.63M 3.67M 3.67M 21M
Shares Outstanding (Diluted) 3.63M 3.63M 3.63M 3.67M 3.67M 21M
EPS (Basic) -1.7 -2.41 3.12 2.06 2.05 0.36
EPS (Diluted) -1.7 -2.41 3.12 2.06 2.05 0.36
EBITDA -3.22M -7.33M 14.2M 10.61M 10.17M 10.11M
Depreciation & Amortization 508.79K 533.95K 446.88K 410.08K 418.43K 452.73K